journal article·2024-03

Engineering Ternary PdMop Nanoenzyme for Enzyodynamic Effect‐Enhanced Ferroptosis and Sonocatalysis‐Enabled Tumor Immunotherapy

Xinran Song, Jiefu Liu, Wenrong Wang, Li Ding, Wei Feng, Tingting Zhang, Yu Chen, Xuejun Ni

Advanced Functional Materials· Volume 34· Issue 10
Publisher page

Abstract

Abstract Immunotherapy has become one of the most effective therapeutic modalities for achieving long‐term cancer remission, but the available immunotherapeutic strategies suffer from modest response rates owing to the insufficient immunogenicity of tumor cells. In this work, a nanomedicine strategy for maintaining highly immunogenic tumor cells by inducing cascade‐mediated immunogenic tumor‐cell ferroptosis is proposed and developed. A PdMoP nanoplatform is engineered that not only induces initial immunogenic tumor cell ferroptosis through its multienzyme‐mimicking activities but also accelerates Mo(IV)‐to‐Mo(VI) transition, which aggravates glutathione (GSH) depletion for deactivating glutathione peroxidase 4 (GPX4) enzyme and lead to excessive radical production for promoting p53 expression and reducing SLC7A11, thereby resulting in efficient ferroptosis and apoptosis. Additionally, PdMoP nanoparticles induce the breakdown of hydrogen peroxide into oxygen to alleviate tumor hypoxia, working synergistically with GSH depletion to reverse the immunosuppressive tumor microenvironment. Significant ferroptosis (through the classical p53‐SLC7A11‐GPX4 pathway) is monitored in both in vitro cellular level and in vivo tumor models, achieving effective tumor suppression and elimination. The distinct ultrasound‐enhanced enzyodynamic therapy strategy represents a simple and effective paradigm for treating cancer by nanocatalytic medicine and catalytic biomaterials.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Environmental and Chemical Engineering Shanghai University Shanghai 200444 P. R. China

Department of Medical Ultrasound Affiliated Hospital of Nantong University Nantong 226001 P. R. China

Department of Ultrasound Lianyungang Maternal and Child Health Hospital Lianyungang 222000 P. R. China

Department of Medical Ultrasound National Clinical Research Center of Interventional Medicine Shanghai Tenth People's Hospital Tongji University Cancer Center Tongji University School of Medicine Tongji University Shanghai 200072 P. R. China

Department of Ultrasound The 985th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army Taiyuan 030001 P. R. China

Department of Diving and Hyperbaric Medicine Naval Medical Center (Naval Medical University) Shanghai 200433 P. R. China

Funding

Shanghai Education Development Foundation · Shanghai Municipal Education Commission

References (55)

Show source-provided references
1. 10.1021/jacs.2c1368910.1021/jacs.2c13689 ↗
2. 10.1039/D2CS00848C10.1039/D2CS00848C ↗
3. 10.1002/adma.20210115510.1002/adma.202101155 ↗
4. 10.1038/s41551-020-0599-510.1038/s41551-020-0599-5 ↗
5. 10.1038/nrclinonc.2015.20910.1038/nrclinonc.2015.209 ↗
6. 10.1038/s41418-017-0012-410.1038/s41418-017-0012-4 ↗
7. 10.1016/j.cell.2017.09.02110.1016/j.cell.2017.09.021 ↗
8. 10.1038/s41571-020-00462-010.1038/s41571-020-00462-0 ↗
9. 10.1111/hdi.1256010.1111/hdi.12560 ↗
10. 10.1007/s40264-019-00868-510.1007/s40264-019-00868-5 ↗
11. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
12. 10.1016/j.ccell.2019.04.00210.1016/j.ccell.2019.04.002 ↗
13. 10.1126/sciadv.abn294110.1126/sciadv.abn2941 ↗
14. 10.1021/jacs.8b0871410.1021/jacs.8b08714 ↗
15. 10.1002/adfm.20190795410.1002/adfm.201907954 ↗
16. 10.1016/j.cej.2020.12721210.1016/j.cej.2020.127212 ↗
17. 10.1016/j.cell.2013.12.01010.1016/j.cell.2013.12.010 ↗
18. 10.1038/s41589-020-0501-510.1038/s41589-020-0501-5 ↗
19. Li J. · Cell Death Dis. · 2020 · 3 · 11
20. 10.1126/sciadv.aax134610.1126/sciadv.aax1346 ↗
21. 10.1038/s41419-020-2384-510.1038/s41419-020-2384-5 ↗
22. 10.1002/anie.20190972910.1002/anie.201909729 ↗
23. 10.1002/adma.20210890810.1002/adma.202108908 ↗
24. 10.1021/acs.chemrev.8b0067210.1021/acs.chemrev.8b00672 ↗
25. 10.1002/anie.20190157510.1002/anie.201901575 ↗
26. 10.1002/adma.20220881710.1002/adma.202208817 ↗
27. 10.1002/adma.20230296110.1002/adma.202302961 ↗
28. 10.1002/adma.20221225910.1002/adma.202212259 ↗
29. Wang Z. · MedComm – Biomater. Appl. · 2023 · 2
30. 10.1021/acssuschemeng.0c0737010.1021/acssuschemeng.0c07370 ↗
31. 10.1038/s41586-019-1603-710.1038/s41586-019-1603-7 ↗
32. 10.1038/ncomms1413610.1038/ncomms14136 ↗
33. 10.1002/adma.20220958910.1002/adma.202209589 ↗
34. 10.1002/EXP.2021001010.1002/EXP.20210010 ↗
35. 10.1002/anie.20201301510.1002/anie.202013015 ↗
36. 10.1002/adma.20230756810.1002/adma.202307568 ↗
37. 10.1038/s41467-019-14199-710.1038/s41467-019-14199-7 ↗
38. 10.1038/s41467-018-05798-x10.1038/s41467-018-05798-x ↗
39. 10.1038/s41467-018-03903-810.1038/s41467-018-03903-8 ↗
40. 10.1002/anie.20230557610.1002/anie.202305576 ↗
41. 10.1002/adma.20221225910.1002/adma.202212259 ↗
42. 10.3390/cancers1106076110.3390/cancers11060761 ↗
43. 10.1016/j.cell.2012.04.02610.1016/j.cell.2012.04.026 ↗
44. 10.1038/s41422-020-00441-110.1038/s41422-020-00441-1 ↗
45. 10.1038/s41392-020-00428-910.1038/s41392-020-00428-9 ↗
46. 10.1039/D0CS00718H10.1039/D0CS00718H ↗
47. 10.1002/anie.20190972910.1002/anie.201909729 ↗
48. 10.1016/j.nantod.2023.10193610.1016/j.nantod.2023.101936 ↗
49. 10.1002/adma.20210890810.1002/adma.202108908 ↗
50. 10.1038/s41584-018-0109-210.1038/s41584-018-0109-2 ↗
51. 10.1016/j.biomaterials.2023.12209010.1016/j.biomaterials.2023.122090 ↗
52. 10.1002/adfm.20230319510.1002/adfm.202303195 ↗
53. 10.1126/scitranslmed.aaa126010.1126/scitranslmed.aaa1260 ↗
54. 10.1002/adma.20221120510.1002/adma.202211205 ↗
55. 10.1002/adhm.20220170510.1002/adhm.202201705 ↗